1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
2
|
Bockelman C and Glimelius B: Need for
adjuvant chemotherapy after colon cancer surgery-has it decreased?
Acta Oncol. 56:629–633. 2017. View Article : Google Scholar : PubMed/NCBI
|
3
|
Hewish M, Lord CJ, Martin SA, Cunningham D
and Ashworth A: Mismatch repair deficient colorectal cancer in the
era of personalized treatment. Nat Rev Clin Oncol. 7:197–208. 2010.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Lee K, Tosti E and Edelmann W: Mouse
models of DNA mismatch repair in cancer research. DNA Repair.
38:140–146. 2016. View Article : Google Scholar : PubMed/NCBI
|
5
|
Kawakami H, Zaanan A and Sinicrope FA:
Microsatellite instability testing and its role in the management
of colorectal cancer. Curr Treat Options Oncol. 16:302015.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Tejpar S, Saridaki Z, Delorenzi M, Bosman
F and Roth AD: Microsatellite instability, prognosis and drug
sensitivity of stage II and III colorectal cancer: More complexity
to the puzzle. J Natl Cancer Inst. 103:841–844. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Supek F and Lehner B: Differential DNA
mismatch repair underlies mutation rate variation across the human
genome. Nature. 521:81–84. 2015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Ray U and Roy SS: Aberrant lipid
metabolism in cancer cells-the role of oncolipid-activated
signaling. FEBS J. 285:432–443. 2018. View Article : Google Scholar : PubMed/NCBI
|
9
|
Beloribi-Djefaflia S, Vasseur S and
Guillaumond F: Lipid metabolic reprogramming in cancer cells.
Oncogenesis. 5:e1892016. View Article : Google Scholar : PubMed/NCBI
|
10
|
Wenk MR: Lipidomics: New tools and
applications. Cell. 143:888–895. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Deng L, Gu H, Zhu J, Nagana Gowda GA,
Djukovic D, Chiorean EG and Raftery D: Combining NMR and LC/MS
Using Backward Variable Elimination: Metabolomics Analysis of
Colorectal Cancer, Polyps, and Healthy Controls. Anal Chem.
88:7975–7983. 2016. View Article : Google Scholar : PubMed/NCBI
|
12
|
Cannavo E, Marra G, Sabates-Bellver J,
Menigatti M, Lipkin SM, Fischer F, Cejka P and Jiricny J:
Expression of the MutL homologue hMLH3 in human cells and its role
in DNA mismatch repair. Cancer Res. 65:10759–10766. 2005.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Drummond JT, Genschel J, Wolf E and
Modrich P: DHFR/MSH3 amplification in methotrexate-resistant cells
alters the hMutSalpha/hMutSbeta ratio and reduces the efficiency of
base-base mismatch repair. Proc Natl Acad Sci USA. 94:10144–10149.
1997. View Article : Google Scholar : PubMed/NCBI
|
14
|
Kantelinen J, Kansikas M, Korhonen MK,
Ollila S, Heinimann K, Kariola R and Nyström M: MutSbeta exceeds
MutSalpha in dinucleotide loop repair. Br J Cancer. 102:1068–1073.
2010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Umar A, Koi M, Risinger JI, Glaab WE,
Tindall KR, Kolodner RD, Boland CR, Barrett JC and Kunkel TA:
Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine
resistance, and defective DNA mismatch repair by introducing
chromosome 2 into human tumor cells with mutations in MSH2 and
MSH61. Cancer Res. 57:3949–3955. 1997.PubMed/NCBI
|
16
|
Folch J, Lees M and Sloane stanley GH: A
simple method for the isolation and purification of total lipides
from animal tissues. J Biol Chem. 226:497–509. 1957.PubMed/NCBI
|
17
|
Luo X, Cheng C, Tan Z, Li N, Tang M, Yang
L and Cao Y: Emerging roles of lipid metabolism in cancer
metastasis. Mol Cancer. 16:762017. View Article : Google Scholar : PubMed/NCBI
|
18
|
Wang H, Zhang Y, Lu Y, Song J, Huang M,
Zhang J and Huang Y: The role of stearoyl-coenzyme A desaturase 1
in clear cell renal cell carcinoma. Tumour Biol. 37:479–489. 2016.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Bagnato C and Igal RA: Overexpression of
diacylglycerol acyltransferase-1 reduces phospholipid synthesis,
proliferation, and invasiveness in simian virus 40-transformed
human lung fibroblasts. J Biol Chem. 278:52203–52211. 2003.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Kim HY, Lee KM, Kim SH, Kwon YJ, Chun YJ
and Choi HK: Comparative metabolic and lipidomic profiling of human
breast cancer cells with different metastatic potentials.
Oncotarget. 7:67111–67128. 2016.PubMed/NCBI
|
21
|
Hilvo M, Denkert C, Lehtinen L, Muller B,
Brockmoller S, Seppänen-Laakso T, Budczies J, Bucher E, Yetukuri L,
Castillo S, et al: Novel theranostic opportunities offered by
characterization of altered membrane lipid metabolism in breast
cancer progression. Cancer Res. 71:3236–3245. 2011. View Article : Google Scholar : PubMed/NCBI
|
22
|
Iorio E, Ricci A, Bagnoli M, Pisanu ME,
Castellano G, Di Vito M, Venturini E, Glunde K, Bhujwalla ZM,
Mezzanzanica D, Canevari S and Podo F: Activation of
phosphatidylcholine cycle enzymes in human epithelial ovarian
cancer cells. Cancer Res. 70:2126–2135. 2010. View Article : Google Scholar : PubMed/NCBI
|
23
|
Menendez JA and Lupu R: Fatty acid
synthase and the lipogenic phenotype in cancer pathogenesis. Nat
Rev Cancer. 7:763–777. 2007. View
Article : Google Scholar : PubMed/NCBI
|